While the use of hydrogels as delivery systems for AMPs is beginning to be explored for applications such as wound dressings and localized infection prevention [52,53,54], AMP dosing is generally not tailored for bacterial pathogens it is intended to treat, and the use of multiple AMPs tethered to hydrogels has not been extensively explored. The gene discussed is ADSL; the disease is infection.